Anti-PM-Scl antibodies positive patients encompass three different groups with distinct prognosis.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac508
Abstract: OBJECTIVE To help identify homogeneous subgroups among patients with anti-polymyositis-scleroderma-antibodies (PM-Scl-Abs) positive auto-immune diseases regardless of diagnostic classifications. METHODS This multicentric (four hospitals) retrospective study collected all consecutive patients (from 2011 to 2021) with positive… read more here.
Keywords: anti scl; skin thickening; scl; scl antibodies ... See more keywords